Sēqster, founded in 2016 to develop technology that enables individuals to aggregate and manage all of their own personal health information, emerged from stealth mode Wednesday.
Comparing itself to the personal finance platform Mint.com, the San Diego startup says its platform integrates personal health information from a variety of sources, including electronic medical records (EMR), wearable devices, and genomics data. The data are integrated in a comprehensive display for each user (see below). The company said it already connects to more than 1,000 healthcare providers, comprising over 2,000 hospitals and clinics nationwide.
In a statement, Sēqster (pronounced seek-ster) said it is establishing partnerships with healthcare providers that will “become the pathway for rolling out its direct-to-consumer offering later this year.” For example, in a separate announcement Wednesday, Seqster outlines its plans under a new partnership with Boston University’s Ryan Center for Sports Medicine & Rehabilitation that could help to create an online community for patients and families with traumatic brain injuries.
“We have created the Sēqster Research Portal which allows any academic or pharmaceutical clinical trial to rapidly enroll participants into their study and aggregate all available health data directly from the source,” Sēqster CEO and co-founder Ardy Arianpour says, according to the statement. “We are proud that Boston University Ryan Center and Dr. Rhoda Au selected Seqster to be their digital health platform that will advance the study and care of brain injury patients.”
The Ryan Center’s proof-of-concept study aims to identify digital biomarkers of traumatic brain injuries among concussed patients and to possibly improve the clinical diagnosis and treatment of head injuries. BU’s study will enroll concussed patients with acute traumatic brain injuries and subjects who participate in contact sports and are currently seeking medical attention at the Ryan Center for either brain injuries or injuries not related to the brain.
Over time, Sēqster said it also plans to offer other services, such as helping patients and their families navigate personal care for both acute and chronic diseases, and to help users enroll in clinical trials for experimental drugs.
Sēqster has been laying plans for a Series A investment round to support its consumer launch, according to a spokesman for the company. It has raised more than $4 million so far in seed funding, and a team of 15.
Arianpour was previously the chief strategy officer for San Diego’s Pathway Genomics and senior vice president for business development at Ambry Genetics. The team also includes co-founder and CTO Xiang “Sean” Li, chief innovation officer Dana Hosseini. Matt Patterson, former medical director of the Naval Special Warfare Center in San Diego and erstwhile McKinsey consultant, is serving as a strategic advisor.